denv-3-lvhc
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 8, 2020 (NCT04298138)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Dengue virusImmunity, active
Dengue virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05967455 | Phase 1 | Oct 30, 2023 | State University of New York, Syracuse, United States Army |
| NCT04298138 | Phase 1 | Mar 8, 2020 | State University of New York, Syracuse, United States Army |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| State University of New York, Syracuse | Academic/Hospital | 2 | 2 | 1 | 2020 |
| United States Army | Government | 2 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1